simvastatin has been researched along with Inflammatory Response Syndrome, Systemic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ALONSO, O; ALVAREZ, FJ; BUSTAMANTE, R; CASTRODEZA, J; LAJO, C; SORIA, S; TAMAYO, E | 1 |
| Gdula-Dymek, A; Krysiak, R; Okopien, B | 1 |
| Chen, KJ; Guo, CY; Huang, Y; Ma, XJ; Shi, DZ; Wu, CF; Xue, M; Yin, HJ | 1 |
| Ahumada, M; Arcas, R; Arribas, JM; Gomez-Plana, J; Marín, F; Martínez, P; Oliver, C; Pascual, DA; Tornel, PL; Valdes, M | 1 |
| Anselmi, A; Chello, M; Covino, E; Di Sciascio, G; Goffredo, C; Patti, G; Spadaccio, C | 1 |
4 trial(s) available for simvastatin and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass.
Topics: Aged; Biomarkers; Cardiopulmonary Bypass; Coronary Artery Bypass; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interleukin-6; Interleukin-8; Leukocyte Count; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Simvastatin; Systemic Inflammatory Response Syndrome; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia.
Topics: Blood Glucose; C-Reactive Protein; Cytokines; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fenofibrate; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Lymphocytes; Male; Metformin; Middle Aged; Monocytes; Prospective Studies; Simvastatin; Systemic Inflammatory Response Syndrome | 2011 |
Preoperative statin therapy and troponin T predict early complications of coronary artery surgery.
Topics: Aged; Atorvastatin; Biomarkers; C-Reactive Protein; Comorbidity; Coronary Artery Bypass; Creatine Kinase, MB Form; Female; Heptanoic Acids; Hospital Mortality; Hospitals, University; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Interleukin-6; Lipids; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pravastatin; Premedication; Preoperative Care; Prospective Studies; Pyrroles; Risk Assessment; Simvastatin; Systemic Inflammatory Response Syndrome; Troponin T | 2006 |
Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery.
Topics: Aged; Apoptosis; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Cytokines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Middle Aged; Neutrophil Activation; Postoperative Complications; Preoperative Care; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Simvastatin; Survival Rate; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2007 |
1 other study(ies) available for simvastatin and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Effect of Chinese drugs for activating blood circulation and detoxifying on indices of thrombosis, inflammatory reaction, and tissue damage in a rabbit model of toxin-heat and blood stasis syndrome.
Topics: Analysis of Variance; Animals; Atherosclerosis; Blood Circulation; Disease Models, Animal; Drugs, Chinese Herbal; Endothelium, Vascular; Immunohistochemistry; Inflammation; Male; Rabbits; Random Allocation; Sensitivity and Specificity; Simvastatin; Systemic Inflammatory Response Syndrome; Thrombosis | 2013 |